This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Author: Avi Kapoor | February 20, 2025 03:45pm

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Loop Capital analyst Mark Schappel initiated coverage on Palantir Technologies Inc. (NASDAQ:PLTR) with a Buy rating and announced a price target of $141. Palantir shares closed at $112.06 on Wednesday. See how other analysts view this stock.
Canaccord Genuity analyst Whitney Ijem initiated coverage on Palvella Therapeutics, Inc. (NASDAQ:PVLA) with a Buy rating and announced a price target of $39. Palvella Therapeutics shares closed at $20.97 on Wednesday. See how other analysts view this stock.
Citigroup analyst Yigal Nochomovitz initiated coverage on Candel Therapeutics, Inc. (NASDAQ:CADL) with a Buy rating and announced a price target of $25. Candel Therapeutics shares closed at $10.47 on Wednesday. See how other analysts view this stock.
Baird analyst Jeff Johnson initiated coverage on Beta Bionics, Inc. (NASDAQ:BBNX) with a Neutral rating and announced a price target of $20. Beta Bionics shares closed at $21.81 on Wednesday. See how other analysts view this stock.
B. Riley Securities analyst Kyle Bauser initiated coverage on Electromed, Inc. (NYSE:ELMD) with a Buy rating and announced a price target of $38. Electromed shares closed at $28.54 on Wednesday. See how other analysts view this stock.